STL reports Q1 FY26 results; continued positive momentum in Revenue and Order Book
YoY growth in Revenue and EBITDA of ~17% and ~94%, respectivelyOrder intake…
NKGen Biotech Administers First Dose of Troculeucel to Alzheimers Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
July 10, 2025 16:30 ET | Source: NKGen Biotech, Inc. SANTA ANA,…
